Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort

BACKGROUND: Botulinum toxin A (BT) is the gold standard treatment for adductor spasmodic dysphonia (AdSD) with established use for greater than thirty years. The spasmodic dysphonia (SD) literature would benefit from additional long-term cohort data, especially in the Canadian population. The goals...

Descripción completa

Detalles Bibliográficos
Autores principales: French, Gabrielle, Bosch, J. Douglas, Randall, Derrick R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961226/
https://www.ncbi.nlm.nih.gov/pubmed/31937363
http://dx.doi.org/10.1186/s40463-020-0401-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961226/
https://www.ncbi.nlm.nih.gov/pubmed/31937363
http://dx.doi.org/10.1186/s40463-020-0401-4

Ejemplares similares